When we analyzed the sections with triple negative breast cancer (TNBC, n = 48), we found 4 with medium (2+) GRB7 expression, 10 with weak (1+) GRB7 expression, and 34 samples with no GRB7 expression (0). This evidence concerns the gene GRB7 and triple-negative breast carcinoma.